cbdMD, Inc.YCBDNYSE
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank71
5Y CAGR+3.2%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
+3.2%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
3 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 6.27% |
| Q3 2025 | 2.47% |
| Q2 2025 | -3.00% |
| Q1 2025 | -7.12% |
| Q4 2024 | 12.23% |
| Q3 2024 | -11.94% |
| Q2 2024 | 18.22% |
| Q1 2024 | -18.58% |
| Q4 2023 | -5.87% |
| Q3 2023 | -6.68% |
| Q2 2023 | -1.93% |
| Q1 2023 | 2.54% |
| Q4 2022 | -22.58% |
| Q3 2022 | -8.53% |
| Q2 2022 | -10.76% |
| Q1 2022 | 3.29% |
| Q4 2021 | -4.81% |
| Q3 2021 | -7.26% |
| Q2 2021 | -10.49% |
| Q1 2021 | -4.30% |
| Q4 2020 | 5.37% |
| Q3 2020 | 10.00% |
| Q2 2020 | 13.17% |
| Q1 2020 | -7.38% |
| Q4 2019 | 16.85% |
| Q3 2019 | 8.49% |
| Q2 2019 | 42.02% |
| Q1 2019 | 1110.38% |
| Q4 2018 | -67.95% |
| Q3 2018 | -54.57% |
| Q2 2018 | 3.81% |
| Q1 2018 | 347.97% |
| Q4 2017 | -36.29% |
| Q3 2017 | -39.59% |
| Q2 2017 | 26.87% |
| Q1 2017 | 604.84% |
| Q4 2016 | -13.19% |
| Q3 2016 | -40.28% |
| Q2 2016 | 0.00% |